TY - JOUR
T1 - Exovascular application of epigallocatechin-3-O-gallate-releasing electrospun poly(l-lactide glycolic acid) fiber sheets to reduce intimal hyperplasia in injured abdominal aorta
AU - Lee, Mi Hee
AU - Kwon, Byeong Ju
AU - Koo, Min Ah
AU - Jang, Eui Hwa
AU - Seon, Gyeung Mi
AU - Park, Jong Chul
N1 - Publisher Copyright:
© 2015 IOP Publishing Ltd.
PY - 2015/9/21
Y1 - 2015/9/21
N2 - Intimal hyperplasia is an excessive ingrowth of tissue resulting in chronic structural lesions commonly found at sites of atherosclerotic lesions, arterial angioplasty, vascular graft anastomoses, and other vascular abnormalities. Epigallocatechin-3-O-gallate (EGCG) was shown to elicit antioxidant, anti-proliferative, and anti-thrombogenic effects. In this study, we used an electrospinning technique to synthesize EGCG-eluting biodegradable poly(l-lactide glycolic acid) (PLGA) fiber sheets for local delivery of EGCG and investigated the effect of their exovascular application on intimal hyperplasia following balloon-induced abdominal aorta injury in a rabbit experimental model. The morphology of the composite sheets was characterized using scanning electron microscopy and Fourier transform-infrared spectroscopy. EGCG was loaded and dispersed into the PLGA-based electrospun fibers. The EGCG-loaded PLGA sheets exhibited sustained EGCG release following the initial 24 h of burst release in phosphate-buffered saline. In vivo studies demonstrated significant inhibition of intimal hyperplasia following the application of the EGCG-eluting electrospun PLGA fiber sheets, compared with vehicle PLGA controls. In conclusion, our results show that exovascular application of EGCG-eluting PLGA electrospun fiber sheets may provide a useful system for the effective local delivery of drugs for the prevention of intimal hyperplasia.
AB - Intimal hyperplasia is an excessive ingrowth of tissue resulting in chronic structural lesions commonly found at sites of atherosclerotic lesions, arterial angioplasty, vascular graft anastomoses, and other vascular abnormalities. Epigallocatechin-3-O-gallate (EGCG) was shown to elicit antioxidant, anti-proliferative, and anti-thrombogenic effects. In this study, we used an electrospinning technique to synthesize EGCG-eluting biodegradable poly(l-lactide glycolic acid) (PLGA) fiber sheets for local delivery of EGCG and investigated the effect of their exovascular application on intimal hyperplasia following balloon-induced abdominal aorta injury in a rabbit experimental model. The morphology of the composite sheets was characterized using scanning electron microscopy and Fourier transform-infrared spectroscopy. EGCG was loaded and dispersed into the PLGA-based electrospun fibers. The EGCG-loaded PLGA sheets exhibited sustained EGCG release following the initial 24 h of burst release in phosphate-buffered saline. In vivo studies demonstrated significant inhibition of intimal hyperplasia following the application of the EGCG-eluting electrospun PLGA fiber sheets, compared with vehicle PLGA controls. In conclusion, our results show that exovascular application of EGCG-eluting PLGA electrospun fiber sheets may provide a useful system for the effective local delivery of drugs for the prevention of intimal hyperplasia.
UR - http://www.scopus.com/inward/record.url?scp=84947976137&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84947976137&partnerID=8YFLogxK
U2 - 10.1088/1748-6041/10/5/055010
DO - 10.1088/1748-6041/10/5/055010
M3 - Article
C2 - 26391656
AN - SCOPUS:84947976137
VL - 10
JO - Biomedical Materials (Bristol)
JF - Biomedical Materials (Bristol)
SN - 1748-6041
IS - 5
M1 - 055010
ER -